Hall J M, Morton I K
Division of Biomedical Sciences, King's College London, U.K.
Eur J Pharmacol. 1991 Feb 7;193(2):231-8. doi: 10.1016/0014-2999(91)90041-n.
We have investigated the receptors and associated coupling mechanisms that mediate the smooth muscle relaxant response to bradykinin (BK) in the rat duodenum in vitro. Relaxation in response to BK seems due to a direct action on the longitudinal smooth muscle since effects were demonstrable in the presence of ibuprofen, mepyramine, atropine, guanethidine (all 1 microM), hexamethonium (10 microM) and TTX (0.3 microM). Receptors involved are of the B2 subtype since agonists and antagonists active at B1 receptors were essentially inactive, and the B2 receptor antagonist Lys,Lys-[Hyp3,Thi5,8,D-Phe7]BK was a potent competitive antagonist of BK-induced relaxation (pKB of 7.2 +/- 0.1). The activity of both BK and the antagonist were unchanged by the presence of peptidase inhibitors including the carboxypeptidase inhibitor DL-2-mercaptomethyl-3-guanidinoethylthiopropanoic acid (mergetpa, 10 microM), which prevents conversion of BK analogues to des-Arg9-B1-active products. In high-K+ solution, BK (0.1-10 microM) produced concentration-related increases in 86Rb efflux. Both this permeability increase in high-K+ solution, and the relaxant responses in Krebs solution, were inhibited by low concentrations (10-100 nM) of apamin, as well as the B2 receptor antagonist Lys,Lys-[Hyp3,Thi5,8,D-Phe7]BK (1 microM). These results are compatable with the proposal that BK-evoked relaxation of the rat duodenum is mediated via a subset of B2 receptors for which the antagonist Lys,Lys-[Hyp3,Thi5,8,D-Phe7]BK has a high affinity, and results from stabilisation of the smooth muscle membrane through the opening of apamin-sensitive 86Rb-permeable calcium-activated K+ channels.
我们研究了介导大鼠十二指肠平滑肌对缓激肽(BK)产生舒张反应的受体及相关偶联机制。体外实验中,BK引起的舒张似乎是由于其对纵行平滑肌的直接作用,因为在存在布洛芬、美吡拉敏、阿托品、胍乙啶(均为1微摩尔)、六甲铵(10微摩尔)和TTX(0.3微摩尔)时仍可观察到效应。所涉及的受体为B2亚型,因为作用于B1受体的激动剂和拮抗剂基本无活性,且B2受体拮抗剂Lys,Lys-[Hyp3,Thi5,8,D-Phe7]BK是BK诱导舒张的强效竞争性拮抗剂(pKB为7.2±0.1)。包括羧肽酶抑制剂DL-2-巯基甲基-3-胍基乙基硫代丙酸(mergetpa,10微摩尔)在内的肽酶抑制剂的存在并未改变BK和拮抗剂的活性,mergetpa可防止BK类似物转化为去-Arg9-B1活性产物。在高钾溶液中,BK(0.1 - 10微摩尔)使86Rb外流呈浓度依赖性增加。低浓度(10 - 100纳摩尔)的蜂毒明肽以及B2受体拮抗剂Lys,Lys-[Hyp3,Thi5,8,D-Phe7]BK(1微摩尔)均可抑制高钾溶液中这种通透性增加以及克雷布斯溶液中的舒张反应。这些结果与以下观点一致,即BK诱发的大鼠十二指肠舒张是通过一部分对拮抗剂Lys,Lys-[Hyp3,Thi5,8,D-Phe7]BK具有高亲和力的B2受体介导的,并且是通过打开蜂毒明肽敏感的86Rb可通透的钙激活钾通道使平滑肌膜稳定化所致。